Quick Answer
GOLDENWELL BIOTECH, INC. reported Gross Profit of $64.00 for fiscal year 2024.
GOLDENWELL BIOTECH, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | $64.00 | -90.4% |
| 2023 | $666.00 | -97.4% |
| 2022 | $25.2K | +200.3% |
| 2021 | $8.4K | — |
| 2020 | $0.00 | — |
| 2019 | $0.00 | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $25.0K | — | -33.3% |
| June 30, 2025 | $37.5K | +53471.4% | — |
| March 31, 2025 | $0.00 | — | — |
| September 30, 2024 | $0.00 | -100.0% | -100.0% |
| June 30, 2024 | $70.00 | -49.3% | — |
| March 31, 2024 | $0.00 | -100.0% | -100.0% |
| September 30, 2023 | $186.00 | -99.2% | +34.8% |
| June 30, 2023 | $138.00 | -92.9% | -80.6% |
- GOLDENWELL BIOTECH, INC. showed a decrease of -90.4% in Gross Profit compared to the prior fiscal year.
- The most recent figure is from GOLDENWELL BIOTECH, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: